Related Experiment Videos
Clinical trial insurance in a comparative law perspective
1Faculty of Health Sciences, Department of Health Law, Maastricht University, The Netherlands.
Medicine and Law
|July 24, 2004
Summary
This study compares clinical trial liability and insurance across Europe. While trial subject compensation is generally protected, legal frameworks vary significantly, lacking justification for differential treatment based on trial type or researcher status.
Area of Science:
- Legal Studies
- Medical Law
- Comparative Law
Background:
- Clinical trials are essential for medical advancement but carry inherent risks for participants.
- Ensuring adequate compensation and clear liability frameworks for clinical trial participants is a critical legal and ethical consideration.
- Existing legal regimes for clinical trial liability and insurance exhibit significant cross-national variation.
Purpose of the Study:
- To conduct a comparative legal analysis of liability and insurance provisions for clinical trials in several European countries.
- To identify commonalities and disparities in the legal protection afforded to clinical trial subjects.
- To evaluate the justification for differentiating compensation based on trial characteristics or researcher affiliation.
Main Methods:
- Comparative legal research methodology.
- Analysis of national legislation and case law in Belgium, France, Germany, the Netherlands, Spain, Switzerland, Sweden, and the United Kingdom.
- Review of insurance regulations pertaining to clinical trials.
Main Results:
- The right to compensation for trial subjects is generally safeguarded across the studied jurisdictions.
- Significant variations exist in the legal regimes governing liability and insurance for clinical trials.
- No objective justification was found for linking compensation levels to the trial's subject matter (drugs vs. non-drugs), nature (therapeutic vs. non-therapeutic), or the researcher's status (public vs. private).
Conclusions:
- While participant rights are protected, the heterogeneity of legal frameworks poses challenges for harmonized clinical trial conduct.
- A unified approach to compensation, independent of trial specifics, would better serve the interests of clinical trial subjects.
- Further harmonization of legal standards for clinical trial liability and insurance is recommended to ensure equitable participant protection across Europe.